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Pancreatic Neuroendocrine Tumor with Atypical 
Radiologic Presentation
Ramandeep Singh M.D., Sean Calhoun D.O., Minchul Shin M.D., and Robert Katz M.D.
An atypical radiographic presentation of a rare non-functional pancreatic neuroendocrine tumor 
as seen on US, CT and MRI is described. Radiographic-pathologic correlation via gross autopsy 
specimens and immuno-histochemical staining demonstrates the pancreas to be markedly en-
larged with extensive calcifications and numerous tiny cysts secondary to diffuse neoplastic infil-
tration without a focal mass.
Neuroendocrine tumors, also known as islet-cell 
tumors, are rare endocrine tumors arising within or 
near the pancreas with an incidence of approximately 5 
cases per million persons per year. A small number may 
occur as part of a multiple endocrine neoplasia type-1 
(MEN-1) [1]. The World Health Organization classifies 
neuroendocrine tumors as well-differentiated or poorly 
differentiated endocrine tumors, although, the tradi-
tional classification of functional and non-functional 
types currently referred to as “syndromic” and “non-
syndromic”, still has wider acceptance [2-4].
Introduction Most neuroendocrine tumors are syndromic and 
secrete hormones leading to a variety of clinical syn-
dromes. Consequently, they are small in size ranging 
from 0.4 to 4 cm at the time of initial diagnosis due to 
earlier symptomatic presentation. On CT scan, func-
tional tumors appear as small homogeneous isodense 
masses that enhance. The common syndromic tumors of 
the pancreas include: insulinomas, gastrinomas, gluca-
gonomas and VIPomas [4-6].
The non-syndromic neuroendocrine tumors are 
mostly diagnosed in patients having abdominal pain due 
to large focal mass or as an incidental finding on imag-
ing studies [7]. On CT scan, non-syndromic tumors 
present as large discrete focal heterogeneous masses 
with calcifications, cysts, necrosis, vascular invasion and 
direct extension or metastases. Classically the pancreatic 
neuroendocrine tumors are hypervascular, enhancing 
during both arterial and venous phases [4-6, 8]. In 
some instances, magnetic resonance imaging (MRI) and 
somatosatostatin receptor scintigraphy are employed to 
further delineate local invasion and metastases.
The following case describes a highly atypical radio-
graphic presentation of a large non-syndromic pancre-
atic neuroendocrine tumors with diffuse enlargement of 
RCR Radiology Case Reports | radiology.casereports.net 2 DOI: 10.2484/rcr.2008.v3i3.162
Pancreatic Neuroendocrine Tumor with Atypical Radiologic Presentation
Figure 1. 46-year-old man with pancreatic neuroendocrine 
tumor. Transverse sonogram of the region of the pancreas 
shows a diffusely enlarged pancreas with extensive calcifi-
cations. PV = Portal Venous Confluence.
A 46-year-old man with past medical history sig-
nificant for gout presented with a one-month history of 
progressive weight loss of 15 pounds, weakness, lethargy, 
and confusion. The patient denied abdominal pain, 
nausea, vomiting, constipation, diarrhea, melena, or 
bleeding. Pertinent physical exam demonstrated mild 
hepatomegaly and an inflammed erythematous right 
great toe. Relevant laboratory values included a mildly 
elevated AST (51 U/L), alkaline phosphatase (198 U/L), 
ammonia level (208 umols/L), elevated lipase (2406 
U/L) and uric acid level (10.4 mg/dl). The patient was 
admitted with a working diagnosis of acute pancreatitis 
and acute exacerbation of gout.
An abdominal sonogram was performed to evaluate 
for gallstone pancreatitis. Marked pancreatic enlarge-
ment was found with extensive speckled calcifications 
and a few cystic areas (Fig.1). In addition, the portal 
vein was dilated and tortuous.
The contrast-enhanced CT demonstrated signs of 
portal hypertension with splenomegaly, portal vein 
engorgement, and esophageal varices. Evaluation of 
Case Report
Figure 2A-B. Contrast-enhanced CT shows a markedly enlarged pancreas with extensive calcifications and cysts.
A B
the pancreas without contour deformity or a focal mass. 
A multi-modality imaging approach using US, CT, and 
MRI with direct comparison is presented and corre-
lated with histological findings and post-autopsy gross 
specimens.
the pancreas revealed it to be markedly enlarged with 
extensive calcifications and a few cysts (Fig.2AB), but 
without surrounding inflammation. Also noted was a 5 
cm lobulated enhancing masses in the dome of the liver 
consistent with an atypical hemangioma or a metastatic 
lesion.
MRI of the abdomen suggested an atypical he-
patic hemangioma (Fig. 3) and confirmed a massively 
enlarged pancreas containing multiple calcifications and 
tiny cysts without contour deformity or involvement 
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Figure 3A-D. MRI shows (A) T1 hypointense and (B) T2 hyperintense hepatic dome lesion with progressive centripetal en-
hancement on (C) portal venous phase and (D) delayed imaging.
of the surrounding soft tissue structures (Fig.4 A-D). 
The T1-weighted fat saturation FSPGR (TR = 120 ms; 
TE = 1.328 ms) images demonstrated the pancreas to 
be isointense to the liver (Fig. 3A). The pancreas was 
slightly increased in intensity with respect to the liver on 
T2-weighted images (TR = 991.744 ms; TE = 118.56 
ms) (Fig. 3B). T1-weighted fat saturation post contrast 
images (TR = 120 ms; TE = 1.328 ms) demonstrated 
minimal enhancement in the arterial phase (Fig. 3C) 
and progressive enhancement in the portal venous phase 
(Fig. 3D). The pancreatic duct and the visualized por-
tions of the pancreatic duct were unremarkable.
The differential diagnosis included an infiltrative 
pancreatic process such as an autoimmune pancreatitis, 
urate pancreatitis, amyloidosis, sarcoid, hemachro-
matosis, granulomatous diseases, or much less likely a 
malignancy.
Histology and Gross Specimens from Autopsy
The patient subsequently underwent exploratory 
laparotomy. The histological sample of the pancreas 
showed a well-differentiated Islet cell neuroendocrine 
tumor with positive immuno-histochemical staining for 
Chromogranin A, Synaptophyisn, and CD 56. The liver 
biopsy showed fibrosis and regenerating micronodules 
consistent with cirrhosis, possibly due to polypeptide 
secretion by the pancreatic neuroendocrine tumor. The 
patient died two months later and a limited autopsy of 
the pancreas again showed a diffusely enlarged infiltrated 
pancreas, which measured 32 x 16 x 11 cm in size and 
weighed 1850 grams (Fig.5). The entire pancreas was 
replaced by a micronodular neuroendocrine tumor with 
RCR Radiology Case Reports | radiology.casereports.net 4 DOI: 10.2484/rcr.2008.v3i3.162
Pancreatic Neuroendocrine Tumor with Atypical Radiologic Presentation
Figure 4A-D. (A) Axial T1 fat saturated MRI showing diffusely enlarged pancreas without pancreatic contour deformity or 
involvement of adjacent soft tissues. (B) Axial T2 MRI demonstrates one of the numerous pancreatic cysts. (C) Axial T1 MRI 
with contrast in arterial phase showing mild pancreatic enhancement. (D) Axial T1 MRI with contrast in portal-venous phase 
showing progressive pancreatic enhancement.
extensive calcifications. Microscopic examination of the 
liver revealed fibrosis and nodule formation consistent 
with early cirrhosis.
Non-syndromic neuroendocrine tumors, such as the 
one presented here, are generally clinically silent and 
consequently present late as large masses. They can grow 
undetected until symptoms develop only as a result of 
their large size, which can vary between 6 and 20 cm 
[7]. Nonfunctional neuroendocrine tumors may secrete 
polypeptides as well however, no clinical manifestations 
Discussion
result. On CT scan, non-syndromic tumors present as 
large discrete focal heterogeneous masses with calcifica-
tions, cysts, necrosis, vascular invasion and direct exten-
sion or metastases. Classically the pancreatic neuroendo-
crine tumors are hypervascular, enhancing during both 
arterial and venous phases [4-6, 8].
The pancreatic neuroendocrine tumor presented in 
our case was quite large, reaching a maximum dimen-
sion of 32 cm and demonstrating enhancement espe-
cially in the portal-venous phase. The intriguing aspect 
of the case from an imaging perspective was the diffuse 
massive pancreatic enlargement without a focal mass 
lesion or contour deformity and with extensive calcifica-
tions.
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Figure 5A-B. (A) Gross specimen shows generalized enlargement of pancreas with extensive nodularity and calcifications 
representing diffuse tumor involvement. (B) Photomicrograph shows uniformity and cellular features typical of neuroendo-
crine tumor (H and E, 100x).
Regarding other possible etiologies, the biliary ducts 
are commonly involved in autoimmune or urate pan-
creatitis. Furthermore, these entities are rarely associated 
with pancreatic calcification thereby making them less 
likely. Pancreatic amyloidosis and sarcoidosis have dif-
fuse or focal pancreatic involvement, which is predomi-
nantly hypoattenuating with or without calcifications, 
and may have biliary duct irregularities [9, 10]. Further-
more, involvement of other organs such as the heart, the 
lungs, or the kidneys is frequently encountered.
Microscopically, both benign and malignant pan-
creatic neuroendocrine tumors have similar appearance. 
Tissue sections show similar cells forming solid nests, 
small glandular or trabecular structures or a ribbon or 
gyriform pattern [5]. Approximately 10-60% of syndro-
mic pancreatic neuroendocrine tumors are potentially 
malignant and up to 80% of non-syndromic tumors can 
be malignant [3, 5], a designation primarily determined 
by finding additional metastatic sites in the liver and 
lymph nodes.
The prognosis is generally poor for such non-func-
tional pancreatic neuroendocrine tumors despite their 
indolent manifestation with a 5-year survival is reported 
as 60-100% for localized disease, 40% for regional, and 
29% for distant metastases [3, 5, and 11]. Treatment 
is surgical resection if discovered early. Given the poor 
prognosis it is important to recognize the various radio-
logical presentations of the pancreatic neuroendocrine 
tumors, including diffuse pancreatic enlargement, which 
has not previously been reported.
1. House MG, Schulick RD. Endocrine tumors of the 
pancreas. Current Opinion in Oncology 2006; 18: 
23-29. [PubMed]
2. Dixon E, Pasieka JL. Functioning and nonfunction-
ing neuroendocrine tumors of the pancreas. Current 
Opinion in Oncology. 19(1): 30-35, January 2007. 
[PubMed]
3. Kaltsas GA, Besser GM, Grossman AB. The Diag-
nosis and Medical Management of Advanced Neu-
roendocrine Tumors. Endocrine Reviews 2004. 25(3): 
458-511. [PubMed]
4. Horton KM, Hruban RH, Yeo C, Fishman EK. 
References
A B
RCR Radiology Case Reports | radiology.casereports.net 6 DOI: 10.2484/rcr.2008.v3i3.162
Pancreatic Neuroendocrine Tumor with Atypical Radiologic Presentation
Multi-detector row CT of pancreatic islet cell tumors. 
Radiographics 2006; 26: 453-464. [PubMed]
5. Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani JA, 
Gagel RF, Sellin RV, Fenoglio CJ, Merrell RC, Hickey 
RC. Nonfunctioning Islet Cell Carcinoma of the Pan-
creas. Surgery 1993; 114: 1175-1182. [PubMed]
6. Sheth S, Hruban RK, Fishman EK. Helical CT of 
islet Cell Tumors of the Pancreas: Typical and Atypi-
cal Manifestations. Am.J.Roentgenol. 2002; 179(3): 
725-730. [PubMed]
7. Furukawa H, Mukai K, Kosuge T, Kanai Y, Shimada 
K, Yamamoto J, Mizuguchi Y, Ushio K. Nonfunctioning 
Islet Cell Tumors of the Pancreas: Clinical, Imaging and 
Pathological Aspects in 16 Patients. Japanese Journal of 
Clinical Oncology 1998; 28(4): 255-261. [PubMed]
8. Eelkema EA, Stephens DH, Ward EM, Sheedy PF 
2nd. CT Features of Nonfunctioning Islet Cell Carci-
noma. AJR 1984; 143: 943-948. [PubMed]
9. Segovia García C, Quilez Barrenechea JI, Vidales 
Aréchaga L, Capelastegui Alber A, De Miguel Herrán 
E. Pancreatic Involvement in Primary Amyloidosis: 
Radiologic Findings. European Radiology, April 2002, 
12: 774-778. [PubMed]
10. To’o KJ, Raman SS, Yu NC, Kim YJ, Crawford T, 
Kadell BM, Lu DS. Pancreatic and Peripancreatic Dis-
eases Mimicking Primary Pancreatic Neoplasia. Radio-
graphics 2005; 25: 949-965. [PubMed]
11. E. Eriksson, K. Oberg and B. Skogseid. Neuroendo-
crine Pancreatic Tumors: Clinical Findings in a Prospec-
tive Study of 84 Patients. Acta Oncologica 1989; 28: 
373-377. [PubMed]
RCR Radiology Case Reports | radiology.casereports.net 7 DOI: 10.2484/rcr.2008.v3i3.162
Pancreatic Neuroendocrine Tumor with Atypical Radiologic Presentation
